New drug OB318 enters human testing for Hard-to-Treat cancers
Disease control
Terminated
This Phase 1 trial tests an experimental drug called OB318 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and to understand how the body processes the drug. Researchers will also look for early signs tha…
Phase: PHASE1 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC